US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 83.450
  • -0.690-0.82%
Close Dec 20 16:00 ET
  • 83.450
  • 0.0000.00%
Post 20:01 ET
8.85BMarket Cap-95.92P/E (TTM)

Intra-Cellular Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
39.23%175.16M
46.44%161.28M
52.90%144.84M
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
204.91%249.13M
242.66%87.43M
Operating revenue
39.23%175.16M
46.44%161.28M
52.90%144.84M
85.51%462.18M
50.41%131.51M
75.05%125.81M
99.96%110.13M
172.57%94.73M
204.91%249.13M
242.66%87.43M
Cost of revenue
67.64%15.3M
58.51%11.35M
46.64%9.9M
65.07%33.75M
57.66%10.7M
56.05%9.13M
54.04%7.16M
113.98%6.75M
154.42%20.44M
167.35%6.79M
Gross profit
37.00%159.86M
45.60%149.92M
53.38%134.94M
87.34%428.43M
49.80%120.8M
76.74%116.68M
104.20%102.97M
178.42%87.98M
210.41%228.69M
250.98%80.65M
Operating expense
35.73%198.7M
18.32%177.65M
14.32%155.9M
19.40%587.81M
20.96%154.9M
20.34%146.39M
8.53%150.14M
30.80%136.37M
37.00%492.32M
17.50%128.06M
Selling and administrative expenses
25.56%132.1M
20.35%121.57M
14.32%113.09M
14.24%409.86M
10.66%104.72M
19.05%105.21M
0.70%101.01M
31.09%98.92M
31.61%358.78M
18.77%94.63M
Research and development costs
60.82%66.82M
12.83%56.18M
12.65%42.83M
33.72%180.14M
49.94%50.77M
24.87%41.55M
29.21%49.79M
30.92%38.02M
51.63%134.72M
14.95%33.86M
Other operating expenses
40.50%-216K
83.13%-112K
96.00%-23K
-85.70%-2.2M
-36.01%-593K
---363K
-31.49%-664K
-138.59%-575K
43.58%-1.18M
-181.29%-436K
Operating profit
-30.75%-38.85M
41.24%-27.72M
56.70%-20.95M
39.54%-159.38M
28.08%-34.1M
46.59%-29.71M
46.34%-47.18M
33.40%-48.39M
7.72%-263.63M
44.87%-47.41M
Net non-operating interest income expense
134.61%12.9M
155.19%11.56M
39.43%6.06M
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
370.41%7.38M
1,154.07%3.39M
Non-operating interest income
134.61%12.9M
155.19%11.56M
39.43%6.06M
175.80%20.34M
76.20%5.97M
159.10%5.5M
243.18%4.53M
693.61%4.35M
370.41%7.38M
1,154.07%3.39M
Other net income (expense)
Income before tax
-7.16%-25.95M
62.10%-16.16M
66.20%-14.89M
45.74%-139.04M
36.10%-28.13M
54.74%-24.22M
50.75%-42.65M
38.93%-44.04M
9.81%-256.25M
48.65%-44.03M
Income tax
769.77%374K
-57.78%57K
3,490.00%359K
10,500.00%636K
448K
4,200.00%43K
135K
100.00%10K
0.00%6K
0
Net income
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
Net income continuous Operations
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
Minority interest income
Net income attributable to the parent company
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.52%-26.32M
62.09%-16.22M
65.39%-15.25M
45.49%-139.67M
35.09%-28.58M
54.66%-24.26M
50.60%-42.78M
38.92%-44.05M
9.81%-256.26M
48.65%-44.03M
Basic earnings per share
0.00%-0.25
64.44%-0.16
65.22%-0.16
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
22.29%-2.72
57.14%-0.45
Diluted earnings per share
0.00%-0.25
64.44%-0.16
65.22%-0.16
46.32%-1.46
33.33%-0.3
56.14%-0.25
51.09%-0.45
41.03%-0.46
22.29%-2.72
57.14%-0.45
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 39.23%175.16M46.44%161.28M52.90%144.84M85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M204.91%249.13M242.66%87.43M
Operating revenue 39.23%175.16M46.44%161.28M52.90%144.84M85.51%462.18M50.41%131.51M75.05%125.81M99.96%110.13M172.57%94.73M204.91%249.13M242.66%87.43M
Cost of revenue 67.64%15.3M58.51%11.35M46.64%9.9M65.07%33.75M57.66%10.7M56.05%9.13M54.04%7.16M113.98%6.75M154.42%20.44M167.35%6.79M
Gross profit 37.00%159.86M45.60%149.92M53.38%134.94M87.34%428.43M49.80%120.8M76.74%116.68M104.20%102.97M178.42%87.98M210.41%228.69M250.98%80.65M
Operating expense 35.73%198.7M18.32%177.65M14.32%155.9M19.40%587.81M20.96%154.9M20.34%146.39M8.53%150.14M30.80%136.37M37.00%492.32M17.50%128.06M
Selling and administrative expenses 25.56%132.1M20.35%121.57M14.32%113.09M14.24%409.86M10.66%104.72M19.05%105.21M0.70%101.01M31.09%98.92M31.61%358.78M18.77%94.63M
Research and development costs 60.82%66.82M12.83%56.18M12.65%42.83M33.72%180.14M49.94%50.77M24.87%41.55M29.21%49.79M30.92%38.02M51.63%134.72M14.95%33.86M
Other operating expenses 40.50%-216K83.13%-112K96.00%-23K-85.70%-2.2M-36.01%-593K---363K-31.49%-664K-138.59%-575K43.58%-1.18M-181.29%-436K
Operating profit -30.75%-38.85M41.24%-27.72M56.70%-20.95M39.54%-159.38M28.08%-34.1M46.59%-29.71M46.34%-47.18M33.40%-48.39M7.72%-263.63M44.87%-47.41M
Net non-operating interest income expense 134.61%12.9M155.19%11.56M39.43%6.06M175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M370.41%7.38M1,154.07%3.39M
Non-operating interest income 134.61%12.9M155.19%11.56M39.43%6.06M175.80%20.34M76.20%5.97M159.10%5.5M243.18%4.53M693.61%4.35M370.41%7.38M1,154.07%3.39M
Other net income (expense)
Income before tax -7.16%-25.95M62.10%-16.16M66.20%-14.89M45.74%-139.04M36.10%-28.13M54.74%-24.22M50.75%-42.65M38.93%-44.04M9.81%-256.25M48.65%-44.03M
Income tax 769.77%374K-57.78%57K3,490.00%359K10,500.00%636K448K4,200.00%43K135K100.00%10K0.00%6K0
Net income -8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M
Net income continuous Operations -8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M
Minority interest income
Net income attributable to the parent company -8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.52%-26.32M62.09%-16.22M65.39%-15.25M45.49%-139.67M35.09%-28.58M54.66%-24.26M50.60%-42.78M38.92%-44.05M9.81%-256.26M48.65%-44.03M
Basic earnings per share 0.00%-0.2564.44%-0.1665.22%-0.1646.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.4622.29%-2.7257.14%-0.45
Diluted earnings per share 0.00%-0.2564.44%-0.1665.22%-0.1646.32%-1.4633.33%-0.356.14%-0.2551.09%-0.4541.03%-0.4622.29%-2.7257.14%-0.45
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List